Vol 28, No 1 (2021)
Research Letter
Published online: 2020-10-27
Perioperative D-dimer levels after transcatheter aortic valve replacement: Comparison of patients with and without anticoagulant therapy
1
, 1, 1, 1, 1, 1, 1, 1, 1
, 1, 1, 1, 1, 1, 1, 1, 1
Abstract
Not available
References
- Jose J, Sulimov DS, El-Mawardy M, et al. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. JACC Cardiovasc Interv. 2017; 10(7): 686–697.
- Yanagisawa R, Hayashida K, Yamada Y, et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC Cardiovasc Imaging. 2016 [Epub ahead of print].
- Olson JD. D-dimer: an overview of hemostasis and fibrinolysis, assays, and clinical applications. Adv Clin Chem. 2015; 69: 1–46.
- Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017; 389(10087): 2383–2392.
- Nijenhuis VJ, Brouwer J, Søndergaard L, et al. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation. Heart. 2019; 105(10): 742–748.
- Nagao T, Hunakubo H, Suzuki M, et al. Trends in physiological coagulation factors in Japanese patients receiving novel oral anticoagulants. J Arrhythm. 2017; 33(2): 117–121.
- Dangas GD, Tijssen JGP, Wöhrle J, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020; 382(2): 120–129.
- De Backer O, Dangas GD, Jilaihawi H, et al. Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med. 2020; 382(2): 130–139.
